STOCK TITAN

InMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly Revenue of $133.6M Represents 21% Year-Over-Year Growth

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) reported record financial results for Q4 and FY 2022. Q4 revenue reached $133.6 million, a 21% increase from Q4 2021, with 83% from surgical technology platforms. GAAP net income for Q4 was $37.7 million, while non-GAAP net income hit $66.4 million. For the full year, revenues reached $454.3 million, a 27% increase, with GAAP net income of $161.5 million. Looking ahead, InMode forecasts revenue between $525 million and $530 million for 2023. Investors can expect a non-GAAP EPS of $2.58 to $2.60.

Positive
  • Record Q4 revenue of $133.6 million, up 21% year-over-year.
  • Record non-GAAP net income of $66.4 million in Q4, up from $55.2 million.
  • Full year revenue of $454.3 million, a 27% increase from 2021.
  • Non-GAAP EPS of $2.42 for 2022, compared to $2.05 in 2021.
  • International revenues increased by 29% year-over-year.
Negative
  • GAAP net income decreased to $37.7 million in Q4 from $52.7 million a year prior.
  • GAAP diluted EPS dropped to $0.44 from $0.61 in Q4 2021.
  • GAAP gross margin decreased to 84% from 85% in Q4 2021.

YOKNEAM, Israel, Feb. 14, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter 2022 Highlights:

  • Record quarterly revenue of $133.6 million, an increase of 21% compared to the fourth quarter of 2021. InMode's proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented 83% of quarterly revenues, while 9% came from InMode's hands-free platforms and 8% from InMode's traditional laser and non-invasive RF platforms.
  • GAAP net income of $37.7 million, compared to $52.7 million in the fourth quarter of 2021; record *non-GAAP net income of $66.4 million, compared to $55.2 million in the fourth quarter of 2021.
  • GAAP diluted earnings per share of $0.44, compared to $0.61 in the fourth quarter of 2021; record *non-GAAP diluted earnings per share of $0.78, compared to $0.64 in the fourth quarter of 2021.
  • Record quarterly revenues from consumables and service of $17.1 million, an increase of 43% compared to the fourth quarter of 2021.

Full Year 2022 Highlights:

  • Record full year revenues of $454.3 million, an increase of 27% as compared to 2021; 81% of revenues derived from our proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments, 10% from our hands-free platforms and 9% from our traditional laser and non-invasive RF platforms
  • GAAP net income of $161.5 million, compared to $165 million in 2021; record *non-GAAP net income of $207.5 million, compared to $176.3 million in 2021
  • GAAP diluted earnings per share of $1.89, compared to $1.92 in 2021; record *non-GAAP diluted earnings per share of $2.42, compared to $2.05 in 2021
  • 29% increase in international (non-U.S.) revenues as compared to 2021

 

U.S. GAAP Results

(U.S. dollars in thousands, except for per share data)


Q4 2022

Q4 2021

FY 2022

FY 2021

Revenues

$133,571

$110,540

$454,271

$357,565

Gross Margins

84 %

85 %

84 %

85 %

Net Income Attributable to InMode Ltd

$37,708

$52,685

$161,520

$164,971

Earnings per Diluted Share

$0.44

$0.61

$1.89

$1.92

*Non-GAAP Results

(U.S. dollars in thousands, except for per share data)


Q4 2022

Q4 2021

FY 2022

FY 2021

Gross Margins

85 %

85 %

84 %

85 %

Net Income Attributable to InMode Ltd

$66,370

$55,193

$207,486

$176,317

Earnings per Diluted Share

$0.78

$0.64

$2.42

$2.05

 

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021. As a result, approximately $313.2 million of the Company's undistributed exempt income for years 2012 through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

Management Comments

"We are happy to report another record revenue year and continuously high profitable growth as we scale globally and reach a yearly revenue run rate nearing $500 million. We are also very happy with the successful launch of the Empower RF, and we remain focused on expanding into additional aesthetic and wellness categories. We are proud to have successfully navigated through the worldwide supply chain challenges in 2022, therefore fulfilling customer orders on time," said Moshe Mizrahy, Chairman and Chief Executive Officer.

Shakil Lakhani, President of InMode North America, commented, "This year demonstrated InMode's ability to expand into new categories and solidified our leadership position in the aesthetics and wellness markets. As our platform sales benefit from a strengthening brand awareness, we also experienced a significant increase in our consumable sales, having sold over 230,000 consumables in the fourth quarter. To further support this market demand, we continue adding talent to our team in North America this year."

"The solid endorsement of the EmpowerRF platform significantly surpassed our most optimistic expectations for the year. Currently, we are conducting six clinical studies focusing on how this technology can positively impact a wide range of health issues for women. In addition, as we continue our strategy and expand into new areas of wellness, we plan to launch the Envision platform for the ophthalmology market during the first half of 2023, followed by the second generation of our hands-free platform for face treatments during the latter half of the year," said Dr. Spero Theodorou, Chief Medical Officer.

Fourth Quarter 2022 Financial Results

Total revenues for the fourth quarter of 2022 reached $133.6 million, an increase of 21% compared to the fourth quarter of 2021.

"We are proud to report another record quarter and year for total revenue, while again maintaining the target gross margin range of over 84%. This derives from our ability to control expenses during global supply chain constraints, while decisively responding to high demand and ensuring orders are delivered on time. Once again, we saw strength from our international operations in the quarter, and we expect that this trend will continue," said Yair Malca, Chief Financial Officer.

InMode applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021.

"I am very pleased that as a result, approximately $313.2 million of the Company's undistributed exempt income for years 2012 through 2021 may be distributed or used without being subject to additional corporate tax," Malca concluded.

GAAP gross margin for the fourth quarter of 2022 was 84% compared to a gross margin of 85% in the fourth quarter of 2021. *Non-GAAP gross margin for the fourth quarter of 2022 and 2021 was 85%.

GAAP operating margin for the fourth quarter of 2022 was 45%, compared to an operating margin of 49% in the fourth quarter of 2021. *Non-GAAP operating margin for the fourth quarter of 2022 was 50% and for the fourth quarter of 2021 was 51%. The decrease in GAAP operating margin is primarily attributable to change in share-based compensation expense.

InMode reported GAAP net income of $37.7 million, or $0.44 per diluted share, in the fourth quarter of 2022, compared to $52.7 million, or $0.61 per diluted share, in the fourth quarter of 2021. On a *non-GAAP basis, InMode reported net income of $66.4 million, or $0.78 per diluted share, in the fourth quarter of 2022, compared to $55.2 million, or $0.64 per diluted share, in the fourth quarter of 2021. The decrease in GAAP net income is primarily attributable to undistributed exempt income.

Full Year 2022 Financial Results

Total revenues for 2022 were $454.3 million, an increase of 27% as compared to 2021. This increase was primarily attributable to strong demand for our minimally invasive platforms. In addition, InMode gained traction in international markets, with international revenues growing 29% year over year.

GAAP gross margin for 2022 was 84%, and the gross margin in 2021 was 85%. *Non-GAAP gross margin for 2022 was 84% and the gross margin in 2021 was 85%.

GAAP operating margin for 2022 was 44%, compared to the operating margin of 47% in 2021. *Non-GAAP operating margin for 2022 was 49%, compared to the operating margin of 50% in the full year of 2021. The decrease in GAAP operating margin is primarily attributable to a change in share-based compensation expense.

InMode reported GAAP net income attributable to InMode Ltd. of $161.5 million, or $1.89 per diluted share, in 2022. This is compared with GAAP net income attributable to InMode Ltd of $165 million, or $1.92 per diluted share, in 2021. On a *non-GAAP basis, InMode reported net income attributable to InMode Ltd. of $207.5 million, or $2.42 per diluted share, in the full year of 2022, compared to net income attributable to InMode Ltd. of $176.3 million, or $2.05 per diluted share, in the full year of 2021.

As of December 31, 2022, InMode had cash and cash equivalents, marketable securities, and short-term bank deposits of $547.4 million.

2023 Financial Outlook

Management provided an outlook for the full year of 2023 ending December 31, 2023. Based on current estimates, management expects:

  • Revenue between $525 million and $530 million
  • *Non-GAAP gross margin between 83% and 85%
  • *Non-GAAP income from operations between $236 million and $238 million
  • *Non-GAAP earnings per diluted share between $2.58 and $2.60

This outlook is not a guarantee of future performance and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021. As a result, approximately $313.2 million of the Company's undistributed exempt income for years 2012 through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

Use of Non-GAAP Financial Measures

In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, and non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

Conference Call Information

Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer, Mr. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, Chief Medical Officer, will host a conference call today, February 14, 2023, at 8:30 a.m. Eastern Time to discuss the fourth quarter 2022 financial results.

The Company encourages participants to pre-register for the conference call using the following link
https://dpregister.com/sreg/10174372/f5819ac374
Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

U.S. Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll- Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=JnMDK7VQ
At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time

The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from February 14, 2023, at 12 p.m. Eastern Time to February 28, 2023, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

Replay Dial-in U.S TOLL-FREE: 1-877-344-7529
Replay Dial-in Canada TOLL-FREE: 855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 3700075

To access the replay using an international dial-in number, please select the link below:
https://services.choruscall.com/ccforms/replay.html

A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the future performance described above under the heading titled "2021 Financial Outlook." Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, including with respect to the impact of the COVID-19 global outbreak. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2022, as well as risk factors relating to the COVID-19 global outbreak and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:

Yair Malca

Chief Financial Officer

Phone: (949) 305-0108

Email: Yair.Malca@inmodemd.com

Investor Relations Contact:

Miri Segal

MS-IR LLC

Phone: (917) 607-8654

Email: ir@inmodemd.com

 

INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)


Three months ended
December 31,

Year Ended
December 31,


2022

2021

2022

2021

REVENUES

133,571

110,540

454,271

357,565

COST OF REVENUES

21,002

16,847

73,485

53,592

GROSS PROFIT

112,569

93,693

380,786

303,973

OPERATING EXPENSES:





Research and development

3,261

2,528

12,425

9,532

Sales and marketing

47,012

35,286

160,576

119,353

General and administrative

2,398

2,527

9,931

8,411

Other Income

-

(800)

-

(800)

TOTAL OPERATING EXPENSES

52,671

39,541

182,932

136,496

INCOME FROM OPERATIONS

59,898

54,152

197,854

167,477

Finance income, net

3,962

118

3,612

525

INCOME BEFORE TAXES

63,860

54,270

201,466

168,002

INCOME TAXES

26,152

1,585

39,946

2,928

NET INCOME

37,708

52,685

161,520

165,074

Less: net income attributable to non-controlling interests

-

-

-

(103)

NET INCOME ATTRIBUTABLE TO INMODE LTD

37,708

52,685

161,520

164,971






NET INCOME PER SHARE:





Basic

0.46

0.63

1.96

2.03

Diluted

0.44

0.61

1.89

1.92

WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING USED IN COMPUTATION OF NET
INCOME PER SHARE (in thousands)





Basic

82,449

83,234

82,482

81,445

Diluted

85,288

86,384

85,404

86,017

 

INMODE LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands, except for per share data)
(Unaudited)


December 31,

2022

December 31,

2021

Assets



CURRENT ASSETS:



Cash and cash equivalents

97,540

68,136

Marketable securities (amortized cost of $384,321 and $296,243, as of December 31, 2022
and 2021, respectively)

374,589

294,530

Short-term bank deposits

75,254

53,248

Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of  December 31,
2022 and 2021, respectively

26,997

20,236

Other receivables

15,094

12,938

Inventories

39,897

21,026

TOTAL CURRENT ASSETS

629,371

470,114

NON-CURRENT ASSETS:



Accounts receivable net of allowance for credit losses of $482 and $0 at December 31, 2022 and
2021, respectively

3,973

768

Deferred income tax asset, net

3,094

1,334

Operating lease right-of-use assets

5,073

4,321

Property and equipment, net

2,298

1,404

Other investments

600

600

TOTAL NON-CURRENT ASSETS

15,038

8,427

TOTAL ASSETS

644,409

478,541

Liabilities and shareholders' equity



CURRENT LIABILITIES:



Accounts payable

16,242

8,779

Contract liabilities

13,798

13,805

Other liabilities

51,980

29,266

TOTAL CURRENT LIABILITIES

82,020

51,850

NON-CURRENT LIABILITIES:



Contract liabilities

3,959

2,751

Other liabilities

303

4,831

Operating lease liabilities

3,509

3,307

TOTAL NON-CURRENT LIABILITIES

7,771

10,889

TOTAL LIABILITIES

89,791

62,739




TOTAL SHAREHOLDERS' EQUITY

554,618

415,802

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

644,409

478,541

 

INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands, except for per share data)
(Unaudited)



Three months ended
December 31,

Year Ended
December 31,


2022

2021

2022

2021

CASH FLOWS FROM OPERATING ACTIVITIES:





Net income

37,708

52,685

161,520

165,074

Adjustments required to reconcile net income to net cash provided by
operating activities:





Depreciation and amortization

218

139

680

517

Share-based compensation expenses

7,148

3,124

24,452

11,962

Change in allowance for credit losses of trade receivable

47

141

449

516

Loss on marketable securities, net

22

142

71

175

Finance expenses (income), net

(2,737)

(375)

(1,210)

1,223

Deferred income taxes, net

(72)

(379)

84

(770)

Changes in operating assets and liabilities:





Decrease (increase) in accounts receivable

805

1,934

(10,415)

(10,544)

Increase in other receivables

(1,081)

(1,982)

(1,787)

(6,400)

Increase in inventories

(4,087)

(1,848)

(18,871)

(6,043)

Increase (decrease) in accounts payable

2,946

(105)

7,463

2,369

Increase (decrease) in other liabilities

14,575

(2,056)

17,941

14,138

Increase in contract liabilities

1,660

1,473

1,201

2,668

Net cash provided by operating activities

57,152

52,893

181,578

174,885

CASH FLOWS FROM INVESTING ACTIVITIES:





Investment in short-term deposits

-

(7,000)

(93,701)

(73,090)

Proceeds from short-term deposits

-

7,000

73,090

69,180

Purchase of fixed assets

(328)

(182)

(1,575)

(939)

Purchase of marketable securities

(70,944)

(70,560)

(168,680)

(273,834)

Proceeds from sale of marketable securities

-

33,785

2,303

93,652

Proceeds from maturity of marketable securities

32,997

6,150

79,089

24,925

Net cash used in investing activities

(38,275)

(30,807)

(109,474)

(160,106)

CASH FLOWS FROM FINANCING ACTIVITIES:





Repurchase of ordinary shares

-

(23,444)

(42,637)

(35,365)

Exercise of options

 

637

540

 

1,552

20,343

Net cash provided by (used in) financing activities

637

(22,904)

(41,085)

(15,022)

EFFECT OF EXCHANGE RATE CHANGES ON CASH

978

26

(1,615)

(559)

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

20,492

(792)

29,404

(802)






CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

77,048

68,928

68,136

68,938

CASH AND CASH EQUIVALENTS AT END OF PERIOD

97,540

68,136

97,540

68,136

 

INMODE LTD.
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
(U.S. dollars in thousands, except for per share data)
(Unaudited)


Three months ended
December 31,

Year Ended
December 31,

2022

2021

2022

2021

Revenues by Category:


















Capital Equipment revenues - United States

80,352

60 %

66,810

60 %

260,992

58 %

211,424

59 %

Capital Equipment revenues - International

36,094

27 %

31,785

29 %

133,220

29 %

107,815

30 %

Total Capital Equipment revenues

116,446

87 %

98,595

89 %

394,212

87 %

319,239

89 %

Consumables and service revenues

17,125

13 %

11,945

11 %

60,059

13 %

38,326

11 %

Total Net Revenue

133,571

100 %

110,540

100 %

454,271

100 %

357,565

100 %













 


Three months ended
December 31,

Year Ended
December 31,

2022

2021

2022

2021


%

%

%

%


United
States

International

Total

United
States

International

Total

United
States

International

Total

United
States

International

Total

Revenues by Technology:













Minimally Invasive

86

76

83

74

70

73

85

74

81

71

73

72

Hands-Free

11

4

9

23

6

17

12

6

10

27

7

20

Non-Invasive

3

20

8

3

24

10

3

20

9

2

20

8


100

100

100

100

100

100

100

100

100

100

100

100

 

INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 
(U.S. dollars in thousands, except for per share data)
(Unaudited)


Three months ended December 31, 2022

Three months ended December 31, 2021

 

 

 

GAAP

 

 

 

Share Based
Compensation

 

 

 

Undistributed Exempt Income

 

 

 

Non-GAAP

 

 

 

GAAP

 

 

 

Share Based
Compensation

 

 

Other Income Related to IP Transactions

 

 

 

Non-GAAP

REVENUES

133,571

-

-

133,571

110,540

-

-

110,540

COST OF REVENUES

21,002

(553)

-

20,449

16,847

(304)

-

16,543

GROSS PROFIT

112,569

553

-

113,122

93,693

304

-

93,997

OPERATING EXPENSES:









Research and development

3,261

(918)

-

2,343

2,528

(442)

-

2,086

Sales and marketing

47,012

(5,069)

-

41,943

35,286

(2,120)

-

33,166

General and administrative

2,398

(608)

-

1,790

2,527

(258)

-

2,269

Other Income

-

-

-

-

(800)

-

800

-

TOTAL OPERATING
EXPENSES

52,671

(6,595)

-

46,076

39,541

(2,820)

800

37,521

INCOME FROM OPERATIONS

59,898

7,148

-

67,046

54,152

3,124

(800)

56,476

Finance income, net

3,962

-

-

3,962

118


-

118

INCOME BEFORE TAXES

63,860

7,148

-

71,008

54,270

3,124

(800)

56,594

INCOME TAXES

26,152

-

(21,514)

4,638

1,585


(184)

1,401

NET INCOME

37,708

7,148

21,514

66,370

52,685

3,124

(616)

55,193










NET INCOME PER SHARE:









Basic

0.46



0.80

0.63



0.66

Diluted

0.44



0.78

0.61



0.64

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING USED IN
COMPUTATION OF NET INCOME
PER SHARE (in thousands)









Basic

82,449



82,449

83,234



83,234

Diluted

85,288



85,515

86,384



86,519

 

INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 
(U.S. dollars in thousands, except for per share data)
(Unaudited)


Year Ended December 31, 2022

Year Ended December 31, 2021

GAAP

Share Based
Compensation

Undistributed Exempt Income

Non-GAAP

GAAP

Share Based
Compensation

 

Other Income Related to IP Transactions

Non-GAAP

REVENUES

454,271

-

-

454,271

357,565

-

-

357,565

COST OF REVENUES

73,485

(1,917)

-

71,568

53,592

(1,108)

-

52,484

GROSS PROFIT

380,786

1,917

-

382,703

303,973

1,108


305,081

OPERATING EXPENSES:









Research and development

12,425

(3,166)

-

9,259

9,532

(1,554)

-

 

7,978

Sales and marketing

160,576

(17,302)

-

143,274

119,353

(8,274)

-

111,079

General and administrative

9,931

(2,067)

-

7,864

8,411

(1,026)

-

 

7,385

Other Income

-

-

-

-

(800)

-

800

-

TOTAL OPERATING
EXPENSES

182,932

(22,535)

-

160,397

136,496

(10,854)

800

126,442

INCOME FROM OPERATIONS

197,854

24,452

-

222,306

167,477

11,962

(800)

178,639

Finance income, net

3,612

-

-

3,612

525

-

-

525

INCOME BEFORE TAXES

201,466

24,452

-

225,918

168,002

11,962

(800)

179,164

INCOME TAXES (TAX BENEFIT)

39,946

-

(21,514)

18,432

2,928

-

(184)

2,744

NET INCOME

161,520

24,452

21,514

207,486

165,074

11,962

(616)

176,420

Less: net income attributable to non-controlling interests

-

-

-

-

(103)

-

-

(103)

NET INCOME ATTRIBUTABLE TO INMODE LTD.

161,520

24,452

21,514

207,486

164,971

11,962

(616)

176,317










NET INCOME PER
SHARE:









Basic

1.96



2.52

2.03



2.16

Diluted

1.89



2.42

1.92



2.05

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)









Basic

82,482



82,482

81,445



81,445

Diluted

85,404



85,628

86,017



86,192

 

Cision View original content:https://www.prnewswire.com/news-releases/inmode-reports-fourth-quarter-and-full-year-2022-financial-results-record-quarterly-revenue-of-133-6m-represents-21-year-over-year-growth-301745737.html

SOURCE InMode LTD

FAQ

What were InMode's Q4 2022 financial results?

InMode reported Q4 2022 revenue of $133.6 million, a 21% increase from Q4 2021, and GAAP net income of $37.7 million.

How did InMode perform in 2022 compared to 2021?

InMode's total revenue for 2022 was $454.3 million, a 27% increase from 2021, with non-GAAP net income of $207.5 million.

What is InMode's earnings per share for Q4 2022?

In Q4 2022, InMode achieved a GAAP diluted EPS of $0.44 and a non-GAAP diluted EPS of $0.78.

What is InMode's revenue outlook for 2023?

InMode expects revenues between $525 million and $530 million for the full year ending December 31, 2023.

InMode Ltd. Ordinary Shares

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Stock Data

1.30B
68.05M
10.76%
64.22%
8.44%
Medical Devices
Healthcare
Link
United States of America
Yokne'am